A Phase 2 Study To Assess The Safety And Efficacy Of Intravitreal ONL1204 Ophthalmic Solution In Subjects With Mac-off Retinal Detachment
Rochester, MN
The purpose of this study is to learn about ONL1204 Ophthalmic Solution in terms of safety and how well the drug works in patients that have a macula-off (central point of vision) rhegmatogenous retinal detachment (RRD).